Cargando…
Irreversible electroporation in primary and metastatic hepatic malignancies: A review
BACKGROUND: Liver cancer makes up a huge percentage of cancer mortality worldwide. Irreversible electroporation (IRE) is a relatively new minimally invasive nonthermal ablation technique for tumors that applies short pulses of high frequency electrical energy to irreversibly destabilize cell membran...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413217/ https://www.ncbi.nlm.nih.gov/pubmed/28445252 http://dx.doi.org/10.1097/MD.0000000000006386 |
_version_ | 1783233141404598272 |
---|---|
author | Lyu, Tianchu Wang, Xifu Su, Zhanliang Shangguan, Junjie Sun, Chong Figini, Matteo Wang, Jian Yaghmai, Vahid Larson, Andrew C. Zhang, Zhuoli |
author_facet | Lyu, Tianchu Wang, Xifu Su, Zhanliang Shangguan, Junjie Sun, Chong Figini, Matteo Wang, Jian Yaghmai, Vahid Larson, Andrew C. Zhang, Zhuoli |
author_sort | Lyu, Tianchu |
collection | PubMed |
description | BACKGROUND: Liver cancer makes up a huge percentage of cancer mortality worldwide. Irreversible electroporation (IRE) is a relatively new minimally invasive nonthermal ablation technique for tumors that applies short pulses of high frequency electrical energy to irreversibly destabilize cell membrane to induce tumor cell apoptosis. METHODS: This review aims to investigate the studies regarding the use of IRE treatment in liver tumors and metastases to liver. We searched PubMed for all of IRE relevant English language articles published up to September 2016. They included clinical trials, experimental studies, observational studies, and reviews. This review manuscript is nothing with ethics issues and ethical approval is not provided. RESULTS: In recent years, increasingly more studies in both preclinical and clinical settings have been conducted to examine the safety and efficacy of this new technique, shedding light on the crucial advantages and disadvantages that IRE possesses. Unlike the current leading thermal ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, IRE requires shorter ablation time without damaging adjacent important vital structures. CONCLUSION: Although IRE has successfully claimed its valuable status in the field of hepatic cancer treatment both preclinical and clinical settings. In order to systemically test and establish its safety and efficacy for clinical applications, more studies still need to be conducted. |
format | Online Article Text |
id | pubmed-5413217 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-54132172017-05-05 Irreversible electroporation in primary and metastatic hepatic malignancies: A review Lyu, Tianchu Wang, Xifu Su, Zhanliang Shangguan, Junjie Sun, Chong Figini, Matteo Wang, Jian Yaghmai, Vahid Larson, Andrew C. Zhang, Zhuoli Medicine (Baltimore) 5700 BACKGROUND: Liver cancer makes up a huge percentage of cancer mortality worldwide. Irreversible electroporation (IRE) is a relatively new minimally invasive nonthermal ablation technique for tumors that applies short pulses of high frequency electrical energy to irreversibly destabilize cell membrane to induce tumor cell apoptosis. METHODS: This review aims to investigate the studies regarding the use of IRE treatment in liver tumors and metastases to liver. We searched PubMed for all of IRE relevant English language articles published up to September 2016. They included clinical trials, experimental studies, observational studies, and reviews. This review manuscript is nothing with ethics issues and ethical approval is not provided. RESULTS: In recent years, increasingly more studies in both preclinical and clinical settings have been conducted to examine the safety and efficacy of this new technique, shedding light on the crucial advantages and disadvantages that IRE possesses. Unlike the current leading thermal ablation techniques, such as radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation, IRE requires shorter ablation time without damaging adjacent important vital structures. CONCLUSION: Although IRE has successfully claimed its valuable status in the field of hepatic cancer treatment both preclinical and clinical settings. In order to systemically test and establish its safety and efficacy for clinical applications, more studies still need to be conducted. Wolters Kluwer Health 2017-04-28 /pmc/articles/PMC5413217/ /pubmed/28445252 http://dx.doi.org/10.1097/MD.0000000000006386 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 5700 Lyu, Tianchu Wang, Xifu Su, Zhanliang Shangguan, Junjie Sun, Chong Figini, Matteo Wang, Jian Yaghmai, Vahid Larson, Andrew C. Zhang, Zhuoli Irreversible electroporation in primary and metastatic hepatic malignancies: A review |
title | Irreversible electroporation in primary and metastatic hepatic malignancies: A review |
title_full | Irreversible electroporation in primary and metastatic hepatic malignancies: A review |
title_fullStr | Irreversible electroporation in primary and metastatic hepatic malignancies: A review |
title_full_unstemmed | Irreversible electroporation in primary and metastatic hepatic malignancies: A review |
title_short | Irreversible electroporation in primary and metastatic hepatic malignancies: A review |
title_sort | irreversible electroporation in primary and metastatic hepatic malignancies: a review |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413217/ https://www.ncbi.nlm.nih.gov/pubmed/28445252 http://dx.doi.org/10.1097/MD.0000000000006386 |
work_keys_str_mv | AT lyutianchu irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT wangxifu irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT suzhanliang irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT shangguanjunjie irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT sunchong irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT figinimatteo irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT wangjian irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT yaghmaivahid irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT larsonandrewc irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview AT zhangzhuoli irreversibleelectroporationinprimaryandmetastatichepaticmalignanciesareview |